Cellectar Biosciences Inc.(CLRB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CLRB Cellectar Biosciences Inc.

休市中 12-12 16:00:00 EST

3.62

-0.16

-4.23%

盘后3.62

+0.000.00%

17:42 EST

最高3.85	最低3.60	成交量5.04万
今开3.70	昨收3.78	日振幅6.61%
总市值1,535万	流通市值1,469万	总股本424.01万
成交额18.56万	换手率1.24%	流通股本405.90万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CLRB","market":"US","secType":"STK","nameCN":"Cellectar Biosciences Inc.","latestPrice":3.62,"timestamp":1765573200000,"preClose":3.78,"halted":0,"volume":50420,"hourTrading":{"tag":"盘后","latestPrice":3.62,"preClose":3.62,"latestTime":"17:42 EST","volume":13,"amount":46.89,"timestamp":1765579376948},"delay":0,"floatShares":4059000,"shares":4240134,"eps":-24.826614,"marketStatus":"休市中","change":-0.16,"latestTime":"12-12 16:00:00 EST","open":3.7,"high":3.85,"low":3.6,"amount":185550.84368,"amplitude":0.066138,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-24.826614,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":3.78,"preHourTrading":{"tag":"盘前","latestPrice":3.7803,"preClose":3.78,"latestTime":"08:00 EST","volume":222,"amount":839.4459582,"timestamp":1765544401986},"postHourTrading":{"tag":"盘后","latestPrice":3.62,"preClose":3.62,"latestTime":"17:42 EST","volume":13,"amount":46.89,"timestamp":1765579376948},"volumeRatio":1.1535663314759035,"impliedVol":1.1856,"impliedVolPercentile":0.9385},"requestUrl":"/m/hq/s/CLRB","defaultTab":"news","newsList":[{"id":"2584992567","title":"Cellectar Biosciences, Inc.盘中异动 早盘股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584992567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584992567?lang=zh_cn&edition=full","pubTime":"2025-11-18 22:32","pubTimestamp":1763476340,"startTime":"0","endTime":"0","summary":"北京时间2025年11月18日22时32分，Cellectar Biosciences, Inc.股票出现波动，股价急速上涨5.14%。截至发稿，该股报3.07美元/股，成交量5361股，换手率0.13%，振幅3.08%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Olema Pharmaceuticals, Inc.、Can Fite Biopharma Ltd、Clearmind Medicine Inc.涨幅较大，Can Fite Biopharma Ltd、Clearmind Medicine Inc.、Aspire Biopharma Holdings, Inc.较为活跃，换手率分别为957.02%、482.47%、265.99%，振幅较大的相关个股有Olema Pharmaceuticals, Inc.、Clearmind Medicine Inc.、Can Fite Biopharma Ltd，振幅分别为46.48%、16.40%、14.20%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118223220a7022478&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118223220a7022478&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"1159984688","title":"Cellectar Biosciences因Iopofosine I 131在复发或难治性儿童高等级胶质瘤中获得美国食品药品管理局的稀有儿童疾病认定","url":"https://stock-news.laohu8.com/highlight/detail?id=1159984688","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159984688?lang=zh_cn&edition=full","pubTime":"2025-10-27 20:30","pubTimestamp":1761568216,"startTime":"0","endTime":"0","summary":"Cellectar Biosciences因Iopofosine I 131在复发或难治性儿童高等级胶质瘤中获得美国食品药品管理局的稀有儿童疾病认定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"1128034086","title":"Cellectar Biosciences：Iopofosine I 131有望于2027年在欧洲获批并商业化上市，用于治疗难治性（BTK抑制剂治疗后）华氏巨球蛋白血症","url":"https://stock-news.laohu8.com/highlight/detail?id=1128034086","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128034086?lang=zh_cn&edition=full","pubTime":"2025-10-06 19:03","pubTimestamp":1759748624,"startTime":"0","endTime":"0","summary":"Cellectar Biosciences：Iopofosine I 131有望于2027年在欧洲获批并商业化上市，用于治疗难治性（BTK抑制剂治疗后）华氏巨球蛋白血症","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"1143563709","title":"Cellectar Biosciences宣布欧洲药品管理局确认其符合条件，可为Iopofosine I 131申请有条件上市许可，用于治疗难治性（BTK抑制剂治疗后）华氏巨球蛋白血症","url":"https://stock-news.laohu8.com/highlight/detail?id=1143563709","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143563709?lang=zh_cn&edition=full","pubTime":"2025-10-06 19:02","pubTimestamp":1759748538,"startTime":"0","endTime":"0","summary":"Cellectar Biosciences宣布，欧洲药品管理局已确认该公司符合条件，可为其药物Iopofosine I 131申请有条件上市许可，该药物用于治疗难治性（BTK抑制剂治疗后）华氏巨球蛋白血症。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"1137012450","title":"Cellectar Biosciences与Evestia Clinical宣布建立合作关系，共同推进三阴性乳腺癌俄歇电子发射放射性药物临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1137012450","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137012450?lang=zh_cn&edition=full","pubTime":"2025-09-24 20:30","pubTimestamp":1758717020,"startTime":"0","endTime":"0","summary":"Cellectar Biosciences与Evestia Clinical宣布建立合作关系，共同推进三阴性乳腺癌俄歇电子发射放射性药物临床试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2568623163","title":"Cellectar Biosciences, Inc.盘中异动 股价大涨5.73%报5.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568623163","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568623163?lang=zh_cn&edition=full","pubTime":"2025-09-18 22:00","pubTimestamp":1758204059,"startTime":"0","endTime":"0","summary":"北京时间2025年09月18日22时00分，Cellectar Biosciences, Inc.股票出现异动，股价快速上涨5.73%。截至发稿，该股报5.35美元/股，成交量4789股，换手率0.15%，振幅3.16%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，89Bio, Inc.、Aptevo Therapeutics Inc.、Psyence Biomedical Ltd.涨幅较大，Aptevo Therapeutics Inc.、Psyence Biomedical Ltd.、Biocardia, Inc.较为活跃，换手率分别为2174.70%、1039.36%、278.25%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Cdt Equity Inc C/Wts 22/09/2028、Psyence Biomedical Ltd.，振幅分别为52.69%、31.75%、31.72%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918220100979b30ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918220100979b30ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2566956503","title":"Cellectar Biosciences, Inc.盘中异动 股价大跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566956503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566956503?lang=zh_cn&edition=full","pubTime":"2025-09-11 02:03","pubTimestamp":1757527412,"startTime":"0","endTime":"0","summary":"北京时间2025年09月11日02时03分，Cellectar Biosciences, Inc.股票出现异动，股价大幅下挫5.29%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.87%。其相关个股中，Cdt Equity Inc C/Wts 22/09/2028、Camp4 Therapeutics Corporation、Revelation Biosciences Inc C/Wts 10/01/2027 涨幅较大，Revelation Biosciences, Inc.、Cdt Equity Inc.、Camp4 Therapeutics Corporation较为活跃，换手率分别为736.41%、219.91%、188.35%，振幅较大的相关个股有Camp4 Therapeutics Corporation、Galecto, Inc.、Cdt Equity Inc C/Wts 22/09/2028，振幅分别为59.30%、54.65%、53.92%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509110203329786a489&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509110203329786a489&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2558566241","title":"Cellectar Biosciences, Inc.盘中异动 股价大跌6.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558566241","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558566241?lang=zh_cn&edition=full","pubTime":"2025-08-12 02:12","pubTimestamp":1754935951,"startTime":"0","endTime":"0","summary":"北京时间2025年08月12日02时12分，Cellectar Biosciences, Inc.股票出现异动，股价快速下挫6.13%。截至发稿，该股报4.44美元/股，成交量5.3731万股，换手率1.88%，振幅4.02%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Equillium, Inc.、Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为6099.31%、628.89%、444.51%，振幅较大的相关个股有Equillium, Inc.、Entero Therapeutics Inc.、Jyong Biotech Ltd.，振幅分别为84.05%、74.27%、62.69%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812021231a48268b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812021231a48268b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2556387697","title":"Cellectar Biosciences, Inc.盘中异动 早盘股价大涨5.51%报4.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556387697","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556387697?lang=zh_cn&edition=full","pubTime":"2025-08-04 21:33","pubTimestamp":1754314383,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日21时33分，Cellectar Biosciences, Inc.股票出现波动，股价急速上涨5.51%。截至发稿，该股报4.98美元/股，成交量5778股，换手率0.20%，振幅1.76%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。其相关个股中，Psyence Biomedical Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029、Soligenix, Inc.涨幅较大，Psyence Biomedical Ltd.、Soligenix, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为2312.75%、831.38%、395.67%，振幅较大的相关个股有Psyence Biomedical Ltd.、Soligenix, Inc.、凯信远达，振幅分别为28.60%、20.62%、15.35%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508042133039732f0bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508042133039732f0bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2556814094","title":"Cellectar Biosciences, Inc.盘中异动 早盘股价大跌5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556814094","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556814094?lang=zh_cn&edition=full","pubTime":"2025-08-01 21:32","pubTimestamp":1754055179,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日21时32分，Cellectar Biosciences, Inc.股票出现异动，股价急速下跌5.74%。截至发稿，该股报4.56美元/股，成交量2.0901万股，换手率0.73%，振幅5.81%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，4D Molecular Therapeutics, Inc.、Bioxcel Therapeutics, Inc.、天境生物涨幅较大，Bioxcel Therapeutics, Inc.、Salarius Pharmaceuticals, Inc.、Artelo Biosciences, Inc.较为活跃，换手率分别为788.60%、110.95%、75.33%，振幅较大的相关个股有Tiziana Life Sciences Ltd、Jyong Biotech Ltd.、4D Molecular Therapeutics, Inc.，振幅分别为20.40%、13.14%、11.33%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801213259a46fe13e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801213259a46fe13e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2555836691","title":"Cellectar Biosciences, Inc.盘中异动 早盘快速上涨5.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555836691","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555836691?lang=zh_cn&edition=full","pubTime":"2025-07-31 21:30","pubTimestamp":1753968641,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日21时30分，Cellectar Biosciences, Inc.股票出现波动，股价快速上涨5.75%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Soligenix, Inc.、Psyence Biomedical Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Onconetix, Inc.、Psyence Biomedical Ltd.、Soligenix, Inc.较为活跃，换手率分别为3600.20%、1715.62%、1675.08%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Psyence Biomedical Ltd.、Soligenix, Inc.，振幅分别为32.00%、17.78%、13.59%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。公司有一个运营和可报告的部门，专注利用PDC平台开发治疗癌症的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731213042a46db2bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731213042a46db2bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2555068327","title":"Cellectar Biosciences, Inc.盘中异动 临近午盘急速跳水5.57%报4.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555068327","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555068327?lang=zh_cn&edition=full","pubTime":"2025-07-29 23:44","pubTimestamp":1753803876,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日23时44分，Cellectar Biosciences, Inc.股票出现异动，股价快速下挫5.57%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Salarius Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Calidi Biotherapeutics, Inc.涨幅较大，Scinai Immunotherapeutics Ltd、Salarius Pharmaceuticals, Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为5321.39%、3358.24%、1634.13%，振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、180 Life Sciences Corp.，振幅分别为136.28%、111.54%、75.60%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507292344369725b830&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507292344369725b830&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2554777318","title":"Cellectar Biosciences, Inc.盘中异动 股价大涨5.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554777318","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554777318?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:31","pubTimestamp":1753709494,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时31分，Cellectar Biosciences, Inc.股票出现波动，股价急速上涨5.70%。截至发稿，该股报5.38美元/股，成交量7653股，换手率0.27%，振幅1.77%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Celcuity Inc.、Aim Immunotech Inc.、Cervomed Inc.涨幅较大，Aim Immunotech Inc.、Cervomed Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为222.14%、80.97%、80.33%，振幅较大的相关个股有Aim Immunotech Inc.、Celcuity Inc.、Lexaria Bioscience Corp.，振幅分别为35.83%、23.86%、10.21%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072821313494bf6e99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072821313494bf6e99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2548209807","title":"Cellectar Biosciences, Inc.盘中异动 股价大涨8.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548209807","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548209807?lang=zh_cn&edition=full","pubTime":"2025-07-03 21:31","pubTimestamp":1751549479,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日21时31分，Cellectar Biosciences, Inc.股票出现波动，股价大幅上涨8.56%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Lixte Biotechnology Holdings, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Windtree Therapeutics, Inc.、Clearmind Medicine Inc.、Lixte Biotechnology Holdings, Inc.较为活跃，换手率分别为1674.50%、513.57%、424.46%，振幅较大的相关个股有Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Lixte Biotechnology Holdings, Inc.、Clearmind Medicine Inc.，振幅分别为27.18%、26.23%、12.17%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703213119a4cd7c01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703213119a4cd7c01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIXT","CLRB","BK4139"],"gpt_icon":0},{"id":"2548832075","title":"Cellectar Biosciences, Inc.7月1日成交额为421.45万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548832075","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548832075?lang=zh_cn&edition=full","pubTime":"2025-07-02 09:33","pubTimestamp":1751420008,"startTime":"0","endTime":"0","summary":"美东时间2025年7月1日，Cellectar Biosciences, Inc.成交额为421.45万美元，成交额较昨日增加322.99%，当日成交量为86.09万股。Cellectar Biosciences, Inc.于2025年7月1日跌31.65%，报4.86美元，该股过去5个交易日跌49.9%，年初至今跌45.82%，过去60日跌44.71%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-01|421.45万|322.99%|86.09万|#|2025-06-30|99.64万|8.17%|12.95万|#|2025-06-27|92.11万|-61.20%|11.86万|#|2025-06-26|237.40万|2.78%|33.12万|#|2025-06-25|230.98万|42.75%|27.63万|Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。公司有一个运营和可报告的部门，专注利用PDC平台开发治疗癌症的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702093658a72968fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702093658a72968fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2548101442","title":"Cellectar Biosciences, Inc.盘中异动 急速下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548101442","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548101442?lang=zh_cn&edition=full","pubTime":"2025-07-01 02:09","pubTimestamp":1751306966,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日02时09分，Cellectar Biosciences, Inc.股票出现异动，股价大幅下挫5.06%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Immatics N V C/Wts 01/07/2025 、Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.涨幅较大，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Inmune Bio Inc.较为活跃，换手率分别为4706.92%、347.00%、121.86%，振幅较大的相关个股有Artelo Biosciences, Inc.、Immatics N V C/Wts 01/07/2025 、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为181.59%、130.77%、66.24%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701020926a726a042&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701020926a726a042&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2546789647","title":"Cellectar Biosciences, Inc.6月27日成交额为92.11万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546789647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546789647?lang=zh_cn&edition=full","pubTime":"2025-06-28 09:33","pubTimestamp":1751074413,"startTime":"0","endTime":"0","summary":"美东时间2025年6月27日，Cellectar Biosciences, Inc.成交额为92.11万美元，成交额较昨日减少61.20%，当日成交量为11.86万股。Cellectar Biosciences, Inc.于2025年6月27日涨7.05%，报7.9美元，该股过去5个交易日跌9.82%，年初至今跌11.93%，过去60日跌9.82%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-27|92.11万|-61.20%|11.86万|#|2025-06-26|237.40万|2.78%|33.12万|#|2025-06-25|230.98万|42.75%|27.63万|#|2025-06-24|161.80万|141.06%|17.97万|#|2025-06-23|67.12万|-44.63%|229.62万|Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。公司有一个运营和可报告的部门，专注利用PDC平台开发治疗癌症的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628093334a4c2358e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628093334a4c2358e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2546275836","title":"Cellectar Biosciences, Inc.6月25日成交额为230.98万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546275836","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546275836?lang=zh_cn&edition=full","pubTime":"2025-06-26 09:34","pubTimestamp":1750901667,"startTime":"0","endTime":"0","summary":"美东时间2025年6月25日，Cellectar Biosciences, Inc.成交额为230.98万美元，成交额较昨日增加42.75%，当日成交量为27.63万股。Cellectar Biosciences, Inc.于2025年6月25日跌18.14%，报7.94美元，该股过去5个交易日跌24.6%，年初至今跌11.48%，过去60日跌21.0%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-25|230.98万|42.75%|27.63万|#|2025-06-24|161.80万|141.06%|17.97万|#|2025-06-23|67.12万|-44.63%|229.62万|#|2025-06-20|121.22万|47.77%|384.31万|#|2025-06-18|82.04万|-7.04%|218.12万|Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。公司有一个运营和可报告的部门，专注利用PDC平台开发治疗癌症的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626093658a71df196&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626093658a71df196&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2546268546","title":"Cellectar Biosciences, Inc.6月24日成交额为161.80万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546268546","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546268546?lang=zh_cn&edition=full","pubTime":"2025-06-25 09:33","pubTimestamp":1750815203,"startTime":"0","endTime":"0","summary":"美东时间2025年6月24日，Cellectar Biosciences, Inc.成交额为161.80万美元，成交额较昨日增加141.06%，当日成交量为17.97万股。Cellectar Biosciences, Inc.于2025年6月24日涨8.57%，报9.7美元，该股过去5个交易日跌15.36%，年初至今涨8.14%，过去60日跌10.19%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-24|161.80万|141.06%|17.97万|#|2025-06-23|67.12万|-44.63%|229.62万|#|2025-06-20|121.22万|47.77%|384.31万|#|2025-06-18|82.04万|-7.04%|218.12万|#|2025-06-17|88.25万|15.41%|241.57万|Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。公司有一个运营和可报告的部门，专注利用PDC平台开发治疗癌症的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625093503a4bc5f3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625093503a4bc5f3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2545842212","title":"Cellectar Biosciences, Inc.6月23日成交额为67.12万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545842212","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545842212?lang=zh_cn&edition=full","pubTime":"2025-06-24 09:33","pubTimestamp":1750728784,"startTime":"0","endTime":"0","summary":"美东时间2025年6月23日，Cellectar Biosciences, Inc.成交额为67.12万美元，成交额较昨日减少44.63%，当日成交量为229.62万股。Cellectar Biosciences, Inc.于2025年6月23日涨2.06%，报0.298美元，该股过去5个交易日跌27.89%，年初至今跌0.4%，过去60日跌18.19%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-23|67.12万|-44.63%|229.62万|#|2025-06-20|121.22万|47.77%|384.31万|#|2025-06-18|82.04万|-7.04%|218.12万|#|2025-06-17|88.25万|15.41%|241.57万|#|2025-06-16|76.47万|-36.25%|196.71万|Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。公司有一个运营和可报告的部门，专注利用PDC平台开发治疗癌症的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624093505a71a47a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624093505a71a47a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cellectar.com","stockEarnings":[{"period":"1week","weight":-0.0398},{"period":"1month","weight":0.0343},{"period":"3month","weight":-0.2874},{"period":"6month","weight":-0.708},{"period":"1year","weight":-0.5429},{"period":"ytd","weight":-0.5964}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cellectar Biosciences, Inc.以前名为Novelos Therapeutics, Inc.于1996年6月成立于特拉华州。2014年2月11日，公司更名为现在的名字。该公司是一家后期临床生物制药公司，专注于癌症治疗药物的发现、开发和商业化。该公司的核心目标是利用专有的磷脂醚药物偶联物递送平台开发PDC，这些PDC旨在专门针对癌细胞，并由于更少的脱靶效应而提供更好的功效和更好的安全性。","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":0.010906},{"month":2,"riseRate":0.636364,"avgChangeRate":0.025528},{"month":3,"riseRate":0.545455,"avgChangeRate":-0.01778},{"month":4,"riseRate":0.181818,"avgChangeRate":-0.105027},{"month":5,"riseRate":0.363636,"avgChangeRate":0.04422},{"month":6,"riseRate":0.363636,"avgChangeRate":-0.071723},{"month":7,"riseRate":0.272727,"avgChangeRate":-0.096298},{"month":8,"riseRate":0.454545,"avgChangeRate":-0.013426},{"month":9,"riseRate":0.416667,"avgChangeRate":-0.024755},{"month":10,"riseRate":0.083333,"avgChangeRate":-0.159758},{"month":11,"riseRate":0.416667,"avgChangeRate":-0.062866},{"month":12,"riseRate":0.416667,"avgChangeRate":-0.047391}],"exchange":"NASDAQ","name":"Cellectar Biosciences Inc.","nameEN":"Cellectar Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cellectar Biosciences Inc.(CLRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cellectar Biosciences Inc.(CLRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cellectar Biosciences Inc.,CLRB,Cellectar Biosciences Inc.股票,Cellectar Biosciences Inc.股票老虎,Cellectar Biosciences Inc.股票老虎国际,Cellectar Biosciences Inc.行情,Cellectar Biosciences Inc.股票行情,Cellectar Biosciences Inc.股价,Cellectar Biosciences Inc.股市,Cellectar Biosciences Inc.股票价格,Cellectar Biosciences Inc.股票交易,Cellectar Biosciences Inc.股票购买,Cellectar Biosciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cellectar Biosciences Inc.(CLRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cellectar Biosciences Inc.(CLRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}